Drug Profile
Buprenorphine/meloxicam sublingual - Bridge therapeutics
Alternative Names: BT 205Latest Information Update: 28 Jun 2021
Price :
$50
*
At a glance
- Originator Bridge Therapeutics
- Class 2 ring heterocyclic compounds; Amides; Cyclopropanes; Morphinans; Non-opioid analgesics; Nonsteroidal anti-inflammatories; Opioid analgesics; Small molecules; Thiazines; Thiazoles
- Mechanism of Action Cyclo-oxygenase 2 inhibitors; Nociceptin receptor agonists; Opioid delta receptor antagonists; Opioid kappa receptor antagonists; Opioid mu receptor agonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- No development reported Pain